Information  X 
Enter a valid email address

Omega Diagnostics delays results release; expects to post annual loss

By BFN News | 01:23 PM | Friday 16 August, 2019

Disease and allergy testing kit provider Omega Diagnostics said it would delay the release of its annual results until September, while warning it expected to post a loss for the period. The company said it needed further time to 'gain clarity regarding certain ongoing commercial discussions and other post-balance sheet events'. Pre-tax losses for the year through March were expected to be £0.2m, narrowing from a loss of £1.0m on-year. Revenue was expected to fall to £9.8m, down from £13.6m, following the sale of the company's infectious disease assets and discontinuation of its German business. Revenue from from continuing operations was seen rising 5% to £8.8m, while Ebitda from continuing operations was expected at £0.2m, turning around an on-year loss of £0.8m. Trading in the first quarter of the new financial year was in line with management expectations, Omega Diagnostics said. At 1:23pm: (LON:ODX) Omega Diagnostics Group PLC share price was -0.5p at 9p Story provided by

a d v e r t i s e m e n t